Tag Archives: says

AstraZeneca’s newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says

Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder.  The Institute for Clinical and… Read More »

Biden says US ‘coming back together,’ but COVID-19 not yet finished

WASHINGTON — Calling a vaccination “the most patriotic thing you can do,” President Joe Biden on Sunday mixed the nation’s birthday party with a celebration of freedom from the worst of the pandemic. He tempered the strides against COVID-19 with a warning that the fight against the virus wasn’t over. “Today, all across this nation,… Read More »

AstraZeneca’s COVID-19 vaccine offers stronger immunity with 45-week gap between doses, company says

A longer, 10-month delay in administering second doses of AstraZeneca’s COVID-19 vaccine afforded trial participants stronger immunity, the company announced Monday, aiming to assuage concerns of compromised immunity among populations of countries with short vaccine supply. Researchers with the University of Oxford posted findings on The Lancet’s preprint server Monday, drawing from trial participants aged… Read More »

Accutane Acne Drug Widely ‘Overused’ Says UK Dermatologist

By Dr. Mercola Up to 50 million Americans struggle with acne, making it the most common skin disorder in the United States.1 When it strikes during the teen years, it can lead to feelings of self-consciousness, embarrassment and depression. Many severe acne sufferers struggle with low self-confidence, feelings of alienation and social withdrawal as a… Read More »